Industry Insights: Genomic Testing for Early-Stage Breast Cancer
March 27, 2026
William Audeh, Chief Medical Officer at Agendia, discusses recent data supporting genomic testing results in guiding clinical decision-making
5 min read
False
Research, trends, news, and views
March 27, 2026
William Audeh, Chief Medical Officer at Agendia, discusses recent data supporting genomic testing results in guiding clinical decision-making
5 min read
March 25, 2026
Study finds elevated phosphorylated tau in AL and ATTR amyloidosis, suggesting a potential blood biomarker for amyloid-related neuropathy
2 min read
March 24, 2026
Optical genome mapping increases variant detection and refines diagnosis and risk stratification
2 min read
March 20, 2026
By Sharjeel Chaudhry
How molecular pathology translates into real patient impact
3 min read
March 18, 2026
Kritika Krishnamurthy shares real-world experience on advanced MPN genomic profiling
7 min read
March 18, 2026
By Mustafa Barbhuiya
CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya
3 min read
March 16, 2026
By Jessica Allerton
Can molecular profiling and AI help uncover tumor origin and actionable biomarkers?
6 min read
March 13, 2026
New research explains how a common cancer gene alters tumor type and may influence treatment response
2 min read
March 13, 2026
By Helen Bristow
A molecular pathologist and a patient advocate discuss bridging the knowledge gap
March 12, 2026
By Jessica Allerton
What earlier mNGS testing could mean for labs and clinicians
4 min read
False
False
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False